Search research articles
Contact Us
Filters
Showing results (11-20 of 80) with videos related to
Page
of 8
Sort By:
Expert Opinion on Investigational Drugs
|
October 16, 2019
Cyclin-dependent kinase (CDK) 9 and 4/6 inhibitors in acute myeloid leukemia (AML): a promising therapeutic approach
Daniel J Lee, Joshua F Zeidner
Leukemia & Lymphoma
|
March 26, 2015
Optimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant
Joshua F Zeidner, B Douglas Smith
Cardiology in Review
|
August 19, 2008
Investigational antiplatelet drugs for the treatment and prevention of coronary artery disease
Joshua F Zeidner, William H Frishman, Robert G Lerner
Current Cancer Drug Targets
|
April 23, 2020
Immune Checkpoint Inhibitors in AML-A New Frontier
Rohit Thummalapalli, Hanna A Knaus, Ivana Gojo, et al.
Leukemia & Lymphoma
|
May 24, 2019
Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET)
Ranjit Joseph, Autumn J McRee, Stephanie Mathews, et al.
Current Treatment Options in Oncology
|
March 17, 2026
Menin Inhibitors: A New Era of Targeted Therapies in Acute Myeloid Leukemia
Daniel T Peters, Jess Hatfield, Mollie Reese, et al.
Current Hematologic Malignancy Reports
|
February 20, 2021
Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options
Daniel R Richardson, Steven D Green, Matthew C Foster, et al.
Seminars in Oncology Nursing
|
November 25, 2019
Advances in Genomic Profiling and Risk Stratification in Acute Myeloid Leukemia
Daniel R Richardson, Matthew C Foster, Catherine C Coombs, et al.
Expert Review of Hematology
|
May 27, 2021
CD123-targeted therapy in acute myeloid leukemia
Manuel Ricardo Espinoza-Gutarra, Steven D Green, Joshua F Zeidner, et al.
The American Journal of Medicine
|
April 20, 2010
The tissue's the issue
Joshua F Zeidner, Edwin J Ostrin, Emily Sydnor, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 80) with videos related to
Sort By:
Page
of 8
Expert Opinion on Investigational Drugs
|
October 16, 2019
Cyclin-dependent kinase (CDK) 9 and 4/6 inhibitors in acute myeloid leukemia (AML): a promising therapeutic approach
Daniel J Lee, Joshua F Zeidner
Leukemia & Lymphoma
|
March 26, 2015
Optimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant
Joshua F Zeidner, B Douglas Smith
Cardiology in Review
|
August 19, 2008
Investigational antiplatelet drugs for the treatment and prevention of coronary artery disease
Joshua F Zeidner, William H Frishman, Robert G Lerner
Current Cancer Drug Targets
|
April 23, 2020
Immune Checkpoint Inhibitors in AML-A New Frontier
Rohit Thummalapalli, Hanna A Knaus, Ivana Gojo, et al.
Leukemia & Lymphoma
|
May 24, 2019
Inversion 16 (inv(16)) acute myeloid leukemia (AML) following treatment with radiation, capecitabine, and temozolomide in a patient with metastatic neuroendocrine tumor (NET)
Ranjit Joseph, Autumn J McRee, Stephanie Mathews, et al.
Current Treatment Options in Oncology
|
March 17, 2026
Menin Inhibitors: A New Era of Targeted Therapies in Acute Myeloid Leukemia
Daniel T Peters, Jess Hatfield, Mollie Reese, et al.
Current Hematologic Malignancy Reports
|
February 20, 2021
Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options
Daniel R Richardson, Steven D Green, Matthew C Foster, et al.
Seminars in Oncology Nursing
|
November 25, 2019
Advances in Genomic Profiling and Risk Stratification in Acute Myeloid Leukemia
Daniel R Richardson, Matthew C Foster, Catherine C Coombs, et al.
Expert Review of Hematology
|
May 27, 2021
CD123-targeted therapy in acute myeloid leukemia
Manuel Ricardo Espinoza-Gutarra, Steven D Green, Joshua F Zeidner, et al.
The American Journal of Medicine
|
April 20, 2010
The tissue's the issue
Joshua F Zeidner, Edwin J Ostrin, Emily Sydnor, et al.
Page
of 8